Khalaf Michel's Form 4 filing
Metlife Inc (MET) · filed Feb 7, 2024
- Accession no.
- 0001099219-24-000030
- Filed
- Feb 7, 2024
- Trade date
- Feb 5, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.35M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Khalaf MichelCIK 0001535491 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | Common Stock | MOption exerciseAcquired | +25,181 | $45.15 | +$1,136,922.15 | 406,447 | Direct | |
| Feb 5, 2024 | Common Stock | SSaleDisposed | −20,460 | $65.95F2 | −$1,349,337 | 385,987 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | Common Stock | MOption exerciseDisposed | −25,181 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $65.94 to $65.97, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney